Two Biochemical Pregnancy Losses: When Does Recurrent Loss Evaluation Begin?

Collect dated urine or blood test results, hCG trends, ultrasound records if any, bleeding dates and treatment-cycle details. Two positive home tests can be meaningful, but the clinician must consider whether results were reliable, whether hCG from a trigger injection could be involved and whether pregnancy location was ever established. Ectopic and molar pregnancies have separate implications. Describe each episode in chronological order without assuming that all positive tests represent exactly the same biological event. Accurate records help the specialist decide what qualifies for evaluation and which immediate safety checks were missed.

The ASRM 2026 opinion defines recurrent pregnancy loss as the spontaneous loss of two or more pregnancies, excluding confirmed ectopic and molar pregnancies, and accepts hCG-confirmed pregnancies. This does not mean every patient needs every possible test. Age, number and timing of losses, known uterine disease, previous embryo testing, medical conditions and personal preferences influence evaluation. The recommendation recognises that early losses are real and may merit attention while discouraging indiscriminate panels. It is reasonable to request a review after two losses rather than being told automatically to wait for a third.

The clinician may assess uterine anatomy and consider genetic investigation of miscarriage tissue if tissue is available in future or past events. Review thyroid disease, diabetes, antiphospholipid syndrome considerations and family history when clinically indicated. Testing should be chosen with a clear explanation of how results change management. Routine broad immune panels, inherited thrombophilia tests or empiric anticoagulants are not established answers for unexplained recurrent loss. Blood tests alone also cannot replace a uterine cavity evaluation when the history points toward an anatomical concern.

Progesterone, aspirin, heparin, steroids and immune therapies are frequently discussed online. Whether any is appropriate depends on diagnosis and circumstances; some are not supported for routine use in unexplained loss. If IVF embryos were genetically screened, that does not rule out all causes of miscarriage or guarantee a pregnancy. Ask for the potential benefit, side effects and quality of evidence before accepting an add-on. Psychological support and compassionate communication are part of proper care even when no definite cause is found.

If hCG is positive again, the medical team should plan appropriate follow-up for pregnancy location and viability rather than relying only on a doubling-time calculator. Severe one-sided pain, fainting, shoulder pain or heavy bleeding warrants urgent assessment for possible ectopic pregnancy or haemorrhage. A safe plan specifies whom to contact, when scans are needed and what is known versus uncertain. Counselling should also address whether a pause, natural conception, IUI or IVF is appropriate; recurrent loss alone does not automatically make IVF the correct treatment.

The HomeIVF approach combines medical supervision with selected home-supported logistics rather than offering “DIY IVF.” Depending on local availability and the case, patients may discuss investigations by teleconsultation, eligible home blood draws, injection guidance or nursing support. These are aids to a doctor-led treatment plan, not replacements for required ultrasound imaging, physical examination, urgent assessment or laboratory procedures. Egg retrieval, embryo culture, ICSI and embryo transfer all need appropriate facilities. For complex diagnoses especially, convenience must never determine whether a medically necessary visit happens. A written plan should identify the responsible clinician, test-result turnaround process and circumstances requiring in-person review.

Consider keeping an early-pregnancy file with test screenshots, laboratory reports, medications, ultrasound results and symptoms. Ask the clinician whether pregnancy location was ever verified in previous episodes. This matters because hCG trends alone do not reliably exclude ectopic pregnancy. If genetic testing of future pregnancy tissue is discussed, ask how and when it could be arranged rather than improvising collection after a loss. Avoid blaming exercise, travel or ordinary everyday activity without evidence. A compassionate care plan also includes how to access counselling and who to contact when waiting for the next test result becomes overwhelming.

A safe plan should also be financially intelligible. Request a stage-by-stage quote, including medication changes, monitoring, specialist referral, anaesthesia or laboratory services if applicable, and what happens if a cycle cannot proceed. Confirm whether future frozen embryo transfers and storage are separate charges. A second opinion is not an obligation to buy another package; it should clarify decisions and help avoid tests or add-ons without a clear indication. If any provider promises a guaranteed result or insists on a deposit before explaining risks, ask for independent clinical advice.

The safest next step is an individualised review of the available records with a qualified fertility clinician and, when needed, a relevant specialist. Ask what is established, what remains uncertain and exactly how a proposed test or treatment would change care. The aim is informed progress, not a guaranteed outcome.